Adult-Gerontology NP Pharmacology Package
The most popular programs on pharmacology for Adult-Gerontology nurse practitioners together at a great price. This comprehensive program was developed to help Adult-Gerontology NPs gain the broad-based pharmacology knowledge needed for clinical practice.
Included Courses
Courses included in this package. Click on a course to learn more.
- Acute Bacterial Rhinosinusitis: A focus on the latest treatment recommendations 1.5 1.5What are the most common risk factors for acute bacterial rhinosinusitis (ABRS)? What are the leading pathogens causing acute sinusitis? What are the current recommendations for assessment and treatment of bacterial sinusitis? Learn the answers to these questions in this case-based program.
- Case Study Approach to Asthma Management: Focus on Pharmacology and Guidelines 1.5 1.5Clinical expert Dr. Wendy L. Wright, DNP, ANP-BC, FNP-BC FAANP, FAAN, FNAP presents the latest asthma statistics, diagnostic criteria, and pharmacologic treatment options, all grounded in evidence-based practices and current guidelines.
- Community Acquired Pneumonia A Contemporary Approach 1.5 1.5
Master complex clinical diagnostics with expert-led case studies covering neutropenia, dengue fever, G6PD deficiency, and thyroid dysfunction - earn CE credits while enhancing your diagnostic skills through real-world scenarios presented by renowned expert clinician, Dr. Margaret Fitzgerald, DNP. FNP-BC, NP-C, FAANP. This evidence-based program provides NPs with advanced clinical decision-making tools and differential diagnosis strategies essential for primary care practice.
- Assessment and Intervention of COPD: The Latest Treatment Recommendations 1.25 1.25Expand your expertise with our program on COPD management.
- Cough, Cold and Fever Symptoms: Pharmacologic Therapies 1.7 1.7
Symptoms associated with upper respiratory tract infection (URI) are among the most common encountered in practice. Dr. Fitzgerald gives prescribing tips in choosing products to help manage common URI symptoms.
- Contraceptive Update: Focus on the Patient with Co-morbidities and Special Considerations 1.5 1.5Enhance your contraceptive management skills with our program focused on patients with co-morbidities and special considerations.
- RX Essentials: Diabetes Update: Focus on the latest recommendations 1.5 1.5Effectively managing type 2 diabetes requires keeping pace with evolving evidence and innovative approaches. Join clinical expert Dr. Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP for an in-depth exploration of the latest recommendations in managing type 2 diabetes.
- Safe Prescribing and Drug - Drug Interactions: Lessons from history 1.5 1.5
Drug–drug interactions are a leading, and preventable, cause of patient harm and a growing source of malpractice liability for nurse practitioners. As polypharmacy rises, so does prescribing risk. In this session, expert clinician Dr. Wendy Wright, DNP, APRN reviews the most clinically significant interaction mechanisms and explores high-risk drug combinations involving statins, anticoagulants, lithium, macrolides, and antivirals, and apply evidence-based strategies to prevent prescribing errors. Topics include herb–drug interactions affecting INR, narrow therapeutic index monitoring, and malpractice risk-reduction through documentation and patient counseling. Real-world prescribing errors reinforce safe, patient-centered practice.
- Laboratory Diagnostics: A Focus on Renal Insufficiency and Failure 1.8 1.8
Dr. Margaret Fitzgerald will help you learn the common and not-so-common risk factors for renal disease, the pathophysiology in renal disease, and the expected laboratory findings in acute and chronic renal disorders.
- Dermatology In the Older Adult 0.7 0.2Hone your ability to identify and manage skins disorders in older patients with this informative program taught by NP dermatology expert Victor Czerkasij, DNP, APRN-BC, FNP-C.
- What's New with AHA/ACC Guidelines for the Management of Lipid Disorders? 1.5 1.5This program presents the most current guideline updates and pharmacologic options for lipid management recommended by the American College of Cardiology/American Heart Association. With a focus on atherosclerotic cardiovascular disease risk reduction, medical history, lipid panel, and CAC scoring are analyzed. Building upon the HMG-CoA reductase inhibitors, additional therapeutic agents for the high-risk patient are considered, with the latest evidence-based analysis of indication, risk, and safety. Cholesterol absorption inhibitors, PCSK9 inhibitors, and ACL inhibitors are all explored as they apply to current guideline-driven management.
- Bacterial Pharyngitis, Acute Bacterial Rhinosinusitis, Acute Otitis Media 2 2
What are the most common risk factors for acute bacterial pharyngitis, acute otitis media, and acute conjunctivitis? What are the leading pathogens causing these conditions?
- Update in Geriatric Prescribing: Beers Criteria, START/STOPP, and Deprescribing 1.75 1.75Explore age- and disease-related physiologic changes in the elderly that influence the selection of safe and effective therapeutic agents.
- Laboratory Monitoring During Drug Therapy 1 1Laboratory monitoring plays a critical role in ensuring safe and effective medication therapy, enhance patient care and medication management with Laboratory Monitoring During Drug Therapy program presented by clinical expert Dr. Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP.
- Principles of Safe Prescribing 3.7 3.7
The art of safe prescribing begins with understanding the importance of a medication's pharmacokinetic (PK) and pharmacodynamic profile.
- Case-based Approach to HTN Management: Combination Therapy is Essential 1.25 1.25Discover the critical role of combination therapy in achieving optimal blood pressure control and minimizing the risk of complications in this comprehensive program.